Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
WOCKPHARMA.NSthis companyWockhardt Limited	₹2,031.50	89.61×	3.86×	5.66×	31.08×	-99.7%	38.2%	11.9%	6.3%	4.3%	4.4%	0.3%	0.45×	2.92×	1.89×	1.61×	0.0%	5	—	1	C-
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
AUROPHARMA.NSAurobindo Pharma Limited	₹1,855.30	21.62×	2×	2.25×	10.17×	130.3%	39.2%	15.1%	10.4%	9.2%	7.3%	3.7%	0.21×	-0.25×	13.22×	1.81×	0.3%	5	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
EMCURE.NSEmcure Pharmaceuticals Ltd.	₹2,216.20	32.72×	6.11×	3.29×	17.14×	-27.7%	38.9%	14.9%	10.0%	18.7%	15.0%	1.6%	0.31×	0.75×	9.56×	1.43×	0.2%	—	—	1	C-
Peer median	—	32.72×	5.32×	3.51×	17.14×	64.5%	41.9%	16.7%	13.8%	12.9%	10.7%	1.6%	0.06×	-0.03×	82.23×	2.64×	1.0%	5	18.51	3	—